ORAL SOLID PREPARATION OF COMPOUND ANTITUBERCULOSIS DRUG AND PREPARATION METHOD THEREOF
申请人:Zhejiang Hisun Pharmaceutical Co. Ltd.
公开号:EP2698150A1
公开(公告)日:2014-02-19
Provided is an oral solid preparation of a compound anti-tubercular drug, wherein the active ingredients are rifampicin, isoniazid, pyrazinamide and ethambutol hydrochloride. The compound oral solid preparation is a coated tablet with coated core or a coated three-layer tablet, wherein the two active ingredients rifampicin and isoniazid do not come to contact with each other directly. The compound oral solid preparation not only improves the stability of the compound preparation, but also improves the bioavailability of rifampicin.
提供了一种复方抗结核药物口服固体制剂,其中有效成分为利福平、异烟肼、吡嗪酰胺和盐酸乙胺丁醇。复方口服固体制剂为包衣片芯或包衣三层片,其中两种有效成分利福平和异烟肼不直接接触。复方口服固体制剂不仅提高了复方制剂的稳定性,还提高了利福平的生物利用度。